ACON Aclarion Corporation: Rasio Kapitalisasi Pasar marang Nilai Buku

Aclarion, Inc. (ACON) - logo korporat

Aclarion (ACON) is implementing a scalable AI system for MRI scan analysis, aiming to integrate its diagnostic tests into US insurance plans. The market capitalization-to-book value multiple exhibits volatility within a sideways trend, where the value 0.28 captures this metric. Strategic alliances with orthopedic centers and cloud-based spinal analytics create powerful data synergy to enhance operational accuracy.

ACON (Aclarion Corporation) riwayat Kapitalisasi Pasar marang Nilai Buku saka 28.04.2023 nganti 27.10.2026

Rincian metrik keuangan lan pasar Aclarion Inc (ACON)

- rega lan prakiraan konsensus rega:
Bagan rega Aclarion|ACON - Prakiraan gabungan firma investasi
- data kapitalisasi pasar:
Kapitalisasi pasar Aclarion Corp|ACON - Nilai Bisnis
- data kapitalisasi buku:
Nilai Buku saben Saham Aclarion|ACON - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku aclarion.com|ACON - Total Aset Perusahaan
- data utang lan likuiditas:
Total Utang marang Modal Aclarion|ACON - Tanggungan utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Aclarion Corp|ACON - Utang agregat perusahaan|Rasio utang marang kapitalisasi buku Aclarion Corp
Pambiji fundamental:Aclarion
Sampel barang Aclarion Corp

For long-term risk management, it is critical to track the gap between market expectations and the actual value of assets. The specificity of Aclarion (ACON) lies in the creation of high-tech AI for the non-invasive analysis of the chemical composition of spinal discs. The price-to-book ratio measures the current market premium over the company's equity. Growth in this metric reflects investor confidence in the commercialization of unique diagnostics, while the stability of this ratio confirms the fundamental resilience of the business.

Pesaing langsung

Rasio Nilai Pasar marang Nilai Buku Abbott Laboratories|thermofisher.com (TMO) - Rasio Kapitalisasi marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku GE HealthCare Technologies (GEHC)|Rasio Kapitalisasi marang Nilai Buku Mettler-Toledo|WAT (Waters Corp.) - Rasio Kapitalisasi Pasar marang Nilai Buku|Kapitalisasi Pasar marang Nilai Buku Bio-Techne Inc. (TECH)|Rasio Kapitalisasi Pasar marang Nilai Buku BRKR (Bruker Corporation)|Rasio Kapitalisasi Pasar marang Nilai Buku azenta.com AZTA|Rasio Kapitalisasi Pasar marang Nilai Buku VREX|SMLR: Rasio Nilai Pasar marang Ekuitas|Rasio Nilai Pasar marang Nilai Buku Butterfly iQ|MLAB (Mesa Laboratories Corp.) - Rasio Kapitalisasi marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku QSI (Quantum-Si)|Koefisien Nilai Pasar marang Nilai Buku NNOX|QTRX (Quanterix) - Rasio Nilai Pasar marang Nilai Buku|Kapitalisasi Pasar marang Nilai Buku 908 Devices Inc MASS|Rasio Kapitalisasi marang Aset Bersih CapsoVision (CV)|Multiplikator Kapitalisasi Pasar marang Nilai Buku MaxCyte Inc MXCT|Rasio Kapitalisasi Pasar marang Nilai Buku RPID (Rapid Micro)|SEER - Kapitalisasi Pasar marang Nilai Buku|HYPR (Hyperfine) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi marang Aset Bersih FONAR Corp.|DXR - Rasio Kapitalisasi marang Aset Bersih|Nilai Pasar marang Nilai Buku MDAI|Rasio Nilai Pasar marang Nilai Buku VIVS (Organovo)|Rasio Kapitalisasi marang Aset Bersih akoyabio.com (AKYA)|THMO: Rasio Kapitalisasi Pasar marang Nilai Buku|Koefisien Nilai Pasar marang Nilai Buku Talis Biomedical Corp. TLIS|T2 Biosystems, Inc (TTOO) - Rasio Kapitalisasi Pasar marang Nilai Buku